-
2
-
-
0003809054
-
-
Cancer AJCo, Springer, New York
-
Cancer AJCo. AJCC Cancer Staging Manual (2002), Springer, New York
-
(2002)
AJCC Cancer Staging Manual
-
-
-
3
-
-
0024711621
-
Revised FIGO staging for gynaecological cancer
-
Shepherd R.H. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 96 8 (1989) 889-892
-
(1989)
Br J Obstet Gynaecol
, vol.96
, Issue.8
, pp. 889-892
-
-
Shepherd, R.H.1
-
4
-
-
0033935907
-
Current management of epithelial ovarian carcinoma: a review
-
Marsden D.E., Friedlander M., and Hacker N.F. Current management of epithelial ovarian carcinoma: a review. Semin Surg Oncol 19 1 (2000) 11-19
-
(2000)
Semin Surg Oncol
, vol.19
, Issue.1
, pp. 11-19
-
-
Marsden, D.E.1
Friedlander, M.2
Hacker, N.F.3
-
5
-
-
0024511529
-
The CA 125 tumour-associated antigen: a review of the literature
-
Jacobs I., and Bast Jr. R.C. The CA 125 tumour-associated antigen: a review of the literature. Human reproduction (Oxford, England) 4 1 (1989 (Jan)) 1-12
-
(1989)
Human reproduction (Oxford, England)
, vol.4
, Issue.1
, pp. 1-12
-
-
Jacobs, I.1
Bast Jr., R.C.2
-
6
-
-
0028952438
-
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer
-
van der Burg M.E., van Lent M., Buyse M., et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 332 10 (1995 (Mar 9)) 629-634
-
(1995)
N Engl J Med
, vol.332
, Issue.10
, pp. 629-634
-
-
van der Burg, M.E.1
van Lent, M.2
Buyse, M.3
-
7
-
-
0024439661
-
Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma
-
Morris M., Gershenson D., Wharton J.T., Copeland L.J., Edwards C.L., and Stringer C.A. Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma. Gyn Oncol 34 (1989) 334-338
-
(1989)
Gyn Oncol
, vol.34
, pp. 334-338
-
-
Morris, M.1
Gershenson, D.2
Wharton, J.T.3
Copeland, L.J.4
Edwards, C.L.5
Stringer, C.A.6
-
8
-
-
0027513786
-
Secondary cytoreduction for ovarian cancer following cisplatin therapy
-
Segna R.A., Dottino P.R., Mandeli J.P., Konsker K., and Cohen C.J. Secondary cytoreduction for ovarian cancer following cisplatin therapy. J Clin Oncol 11 (1993) 434-439
-
(1993)
J Clin Oncol
, vol.11
, pp. 434-439
-
-
Segna, R.A.1
Dottino, P.R.2
Mandeli, J.P.3
Konsker, K.4
Cohen, C.J.5
-
9
-
-
0028321662
-
Experience with positron emission tomography (PET) scans in patients with ovarian cancer
-
Casey M.J., Gupta N.C., and Muths C.K. Experience with positron emission tomography (PET) scans in patients with ovarian cancer. Gynecol Oncol 53 3 (1994 (Jun)) 331-338
-
(1994)
Gynecol Oncol
, vol.53
, Issue.3
, pp. 331-338
-
-
Casey, M.J.1
Gupta, N.C.2
Muths, C.K.3
-
10
-
-
0027742047
-
Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG)
-
Hubner K.F., McDonald T.W., Niethammer J.G., Smith G.T., Gould H.R., and Buonocore E. Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG). Gynecol Oncol 51 2 (1993 (Nov)) 197-204
-
(1993)
Gynecol Oncol
, vol.51
, Issue.2
, pp. 197-204
-
-
Hubner, K.F.1
McDonald, T.W.2
Niethammer, J.G.3
Smith, G.T.4
Gould, H.R.5
Buonocore, E.6
-
11
-
-
0027714787
-
Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-d-glucose can detect recurrent ovarian carcinoma
-
Karlan B.Y., Hawkins R., Hoh C., Lee M., Tse N., Cane P., et al. Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-d-glucose can detect recurrent ovarian carcinoma. Gynecol Oncol 51 2 (1993 (Nov)) 175-181
-
(1993)
Gynecol Oncol
, vol.51
, Issue.2
, pp. 175-181
-
-
Karlan, B.Y.1
Hawkins, R.2
Hoh, C.3
Lee, M.4
Tse, N.5
Cane, P.6
-
12
-
-
0027213273
-
Whole-body positron emission tomography with (fluorine-18)-2-deoxyglucose can detect metastatic carcinoma of the fallopian tube
-
Karlan B.Y., Hoh C., Tse N., Futoran R., Hawkins R., and Glaspy J. Whole-body positron emission tomography with (fluorine-18)-2-deoxyglucose can detect metastatic carcinoma of the fallopian tube. Gynecol Oncol 49 3 (1993 (Jun)) 383-388
-
(1993)
Gynecol Oncol
, vol.49
, Issue.3
, pp. 383-388
-
-
Karlan, B.Y.1
Hoh, C.2
Tse, N.3
Futoran, R.4
Hawkins, R.5
Glaspy, J.6
-
13
-
-
0036062771
-
Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer
-
Cho S.M., Ha H.K., Byun J.Y., Lee J.M., Kim C.J., and Nam-Koong S.E. Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer. AJR Am J Roentgenol 179 2 (2002 (Aug)) 391-395
-
(2002)
AJR Am J Roentgenol
, vol.179
, Issue.2
, pp. 391-395
-
-
Cho, S.M.1
Ha, H.K.2
Byun, J.Y.3
Lee, J.M.4
Kim, C.J.5
Nam-Koong, S.E.6
-
14
-
-
1642586732
-
Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma
-
Kubik-Huch R.A., Dorffler W., von Schulthess G.K., Marincek B., Kochli O.R., Seifert B., et al. Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma. Eur Radiol 10 5 (2000) 761-767
-
(2000)
Eur Radiol
, vol.10
, Issue.5
, pp. 761-767
-
-
Kubik-Huch, R.A.1
Dorffler, W.2
von Schulthess, G.K.3
Marincek, B.4
Kochli, O.R.5
Seifert, B.6
-
15
-
-
0034986738
-
Clinical value of positron emission tomography with FDG for recurrent ovarian cancer
-
Nakamoto Y., Saga T., Ishimori T., Mamede M., Togashi K., Higuchi T., et al. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR Am J Roentgenol 176 6 (2001 (Jun)) 1449-1454
-
(2001)
AJR Am J Roentgenol
, vol.176
, Issue.6
, pp. 1449-1454
-
-
Nakamoto, Y.1
Saga, T.2
Ishimori, T.3
Mamede, M.4
Togashi, K.5
Higuchi, T.6
-
16
-
-
0034936676
-
Positron emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy
-
Rose P.G., Faulhaber P., Miraldi F.D., and Abdul-Karim F.W. Positron emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy. Gynecol Oncol 82 (2001) 17-21
-
(2001)
Gynecol Oncol
, vol.82
, pp. 17-21
-
-
Rose, P.G.1
Faulhaber, P.2
Miraldi, F.D.3
Abdul-Karim, F.W.4
-
17
-
-
0036596897
-
Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-d-glucose
-
Torizuka T., Nobezawa S., Kanno T., Futatsubashi M., Yoshikawa E., Okada H., et al. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-d-glucose. Eur J Nucl Med Mol Imaging 29 6 (2002 (Jun)) 797-803
-
(2002)
Eur J Nucl Med Mol Imaging
, vol.29
, Issue.6
, pp. 797-803
-
-
Torizuka, T.1
Nobezawa, S.2
Kanno, T.3
Futatsubashi, M.4
Yoshikawa, E.5
Okada, H.6
-
18
-
-
0035568909
-
Whole body positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer
-
Yen R.F., Sun S.S., Shen Y.Y., Changlai S.P., and Kao A. Whole body positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer. Anticancer Res 21 5 (2001 (Sep-Oct)) 3691-3694
-
(2001)
Anticancer Res
, vol.21
, Issue.5
, pp. 3691-3694
-
-
Yen, R.F.1
Sun, S.S.2
Shen, Y.Y.3
Changlai, S.P.4
Kao, A.5
-
19
-
-
0034761154
-
2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer
-
Zimny M., Siggelkow W., Schroder W., Nowak B., Biemann S., Rath W., et al. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol 83 2 (2001 (Nov)) 310-315
-
(2001)
Gynecol Oncol
, vol.83
, Issue.2
, pp. 310-315
-
-
Zimny, M.1
Siggelkow, W.2
Schroder, W.3
Nowak, B.4
Biemann, S.5
Rath, W.6
-
20
-
-
15544384862
-
FDG-PET for management of cervical and ovarian cancer
-
Havrilesky L.J., Kulasingam S.L., Matchar D.B., and Myers E.R. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol 97 1 (2005 (Apr)) 183-191
-
(2005)
Gynecol Oncol
, vol.97
, Issue.1
, pp. 183-191
-
-
Havrilesky, L.J.1
Kulasingam, S.L.2
Matchar, D.B.3
Myers, E.R.4
-
21
-
-
0141974973
-
Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT
-
Bristow R.E., del Carmen M.G., Pannu H.K., Cohade C., Zahurak M.L., Fishman E.K., et al. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 90 3 (2003 (Sep)) 519-528
-
(2003)
Gynecol Oncol
, vol.90
, Issue.3
, pp. 519-528
-
-
Bristow, R.E.1
del Carmen, M.G.2
Pannu, H.K.3
Cohade, C.4
Zahurak, M.L.5
Fishman, E.K.6
-
22
-
-
0036223015
-
Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review
-
Makhija S., Howden N., Edwards R., Kelley J., Townsend D.W., and Meltzer C.C. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. Gynecol Oncol 85 1 (2002 (Apr)) 53-58
-
(2002)
Gynecol Oncol
, vol.85
, Issue.1
, pp. 53-58
-
-
Makhija, S.1
Howden, N.2
Edwards, R.3
Kelley, J.4
Townsend, D.W.5
Meltzer, C.C.6
-
23
-
-
34247575293
-
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer
-
Mangili G., Picchio M., Sironi S., Vigano R., Rabaiotti E., Bornaghi D., et al. Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer. Eur J Nucl Med Mol Imaging 34 5 (2007 (May)) 658-666
-
(2007)
Eur J Nucl Med Mol Imaging
, vol.34
, Issue.5
, pp. 658-666
-
-
Mangili, G.1
Picchio, M.2
Sironi, S.3
Vigano, R.4
Rabaiotti, E.5
Bornaghi, D.6
-
24
-
-
23944520611
-
(18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients
-
Nanni C., Rubello D., Farsad M., De Iaco P., Sansovini M., Erba P., et al. (18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients. Eur J Surg Oncol 31 7 (2005 (Sep)) 792-797
-
(2005)
Eur J Surg Oncol
, vol.31
, Issue.7
, pp. 792-797
-
-
Nanni, C.1
Rubello, D.2
Farsad, M.3
De Iaco, P.4
Sansovini, M.5
Erba, P.6
-
25
-
-
2342620155
-
PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation
-
Pannu H.K., Cohade C., Bristow R.E., Fishman E.K., and Wahl R.L. PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation. Abdom Imaging 29 3 (2004 (May-Jun)) 398-403
-
(2004)
Abdom Imaging
, vol.29
, Issue.3
, pp. 398-403
-
-
Pannu, H.K.1
Cohade, C.2
Bristow, R.E.3
Fishman, E.K.4
Wahl, R.L.5
-
26
-
-
33748534206
-
The impact of PET/CT in the management of recurrent ovarian cancer
-
Simcock B., Neesham D., Quinn M., Drummond E., Milner A., and Hicks R.J. The impact of PET/CT in the management of recurrent ovarian cancer. Gynecol Oncol 103 1 (2006 (Oct)) 271-276
-
(2006)
Gynecol Oncol
, vol.103
, Issue.1
, pp. 271-276
-
-
Simcock, B.1
Neesham, D.2
Quinn, M.3
Drummond, E.4
Milner, A.5
Hicks, R.J.6
-
27
-
-
7044232022
-
Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings
-
Sironi S., Messa C., Mangili G., Zangheri B., Aletti G., Garavaglia E., et al. Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings. Radiology 233 2 (2004 (Nov)) 433-440
-
(2004)
Radiology
, vol.233
, Issue.2
, pp. 433-440
-
-
Sironi, S.1
Messa, C.2
Mangili, G.3
Zangheri, B.4
Aletti, G.5
Garavaglia, E.6
-
28
-
-
33947317092
-
Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer
-
Thrall M.M., DeLoia J.A., Gallion H., and Avril N. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer. Gynecol Oncol 105 1 (2007 (Apr)) 17-22
-
(2007)
Gynecol Oncol
, vol.105
, Issue.1
, pp. 17-22
-
-
Thrall, M.M.1
DeLoia, J.A.2
Gallion, H.3
Avril, N.4
-
29
-
-
1642578792
-
PET-CT in recurrent ovarian cancer: initial observations
-
Pannu H.K., Bristow R.E., Cohade C., Fishman E.K., and Wahl R.L. PET-CT in recurrent ovarian cancer: initial observations. Radiographics 24 1 (2004 (Jan-Feb)) 209-223
-
(2004)
Radiographics
, vol.24
, Issue.1
, pp. 209-223
-
-
Pannu, H.K.1
Bristow, R.E.2
Cohade, C.3
Fishman, E.K.4
Wahl, R.L.5
|